(Q48303575)

English

HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

F Möller

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

J Poettgen

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

F Broemel

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

A Neuhaus

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

M Daumer

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

C Heesen

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

publication date

11 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

17

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

1002-1009

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

An electrophysiological study of the mechanism of fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Cytokine mRNA expression in patients with multiple sclerosis and fatigue

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Mental fatigue alters the pattern and increases the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Origin of fatigue in multiple sclerosis: review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Modulatory effects of modafinil on neural circuits regulating emotion and cognition

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Validation of the German version of the brief fatigue inventory.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

A comprehensive review of the Paced Auditory Serial Addition Test (PASAT).

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

The nature of fatigue in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Evaluation of the Modified Fatigue Impact Scale in four different European countries.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Reducing the probability of false positive research findings by pre-publication validation - experience with a large multiple sclerosis database

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Modafinil effects in multiple sclerosis patients with fatigue

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

1 reference

https://api.crossref.org/works/10.1177%2F1352458511402410

21 January 2018

Identifiers

10.1177/1352458511402410

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21561959

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48303575&oldid=2194942266"